NEW YORK (GenomeWeb News) - Several large pharmaceutical firms and academic research groups today kicked off a collaborative effort that will use genomics to attack a central challenge of drug development: the fact that adverse drug reactions affecting only a few patients can hold up or prevent the release of a drug that could help many.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.